|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 188 out of 188 for Sstr5

<< First    < Previous  |  Next >    Last >>
0.024s
Type Details Score
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2002
Title: Mouse Genome Informatics Computational Sequence to Gene Associations
Publication        
First Author: Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas
Year: 2010
Title: Annotation inferences using phylogenetic trees
Publication      
First Author: Bairoch A
Year: 1999
Journal: Database Release
Title: SWISS-PROT Annotated protein sequence database
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication      
First Author: Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI)
Year: 2010
Journal: Database Download
Title: Consensus CDS project
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication      
First Author: Mouse Genome Database and National Center for Biotechnology Information
Year: 2000
Journal: Database Release
Title: Entrez Gene Load
Publication      
First Author: Allen Institute for Brain Science
Year: 2004
Journal: Allen Institute
Title: Allen Brain Atlas: mouse riboprobes
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Mouse Genome Informatics Group
Year: 2003
Journal: Database Procedure
Title: Automatic Encodes (AutoE) Reference
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Publication
First Author: Tallent M
Year: 1996
Journal: Neuroscience
Title: Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20.
Volume: 71
Issue: 4
Pages: 1073-81
Publication
First Author: Ohigashi I
Year: 2010
Journal: PLoS One
Title: Identification of the transgenic integration site in immunodeficient tgε26 human CD3ε transgenic mice.
Volume: 5
Issue: 12
Pages: e14391
Allele
Name: transgene insertion 26, Cox Terhorst
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
Strain
Attribute String: mutant stock, transgenic
Publication
First Author: Wang B
Year: 1994
Journal: Proc Natl Acad Sci U S A
Title: A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene.
Volume: 91
Issue: 20
Pages: 9402-6
Publication
First Author: Sheng-Fowler L
Year: 2014
Journal: PLoS One
Title: A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-Myc.
Volume: 9
Issue: 10
Pages: e108926
Publication
First Author: van Ewijk W
Year: 2000
Journal: Development
Title: Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets.
Volume: 127
Issue: 8
Pages: 1583-91
Publication
First Author: Kechichian TB
Year: 2007
Journal: Infect Immun
Title: Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice.
Volume: 75
Issue: 10
Pages: 4792-8
Publication
First Author: Wang B
Year: 1995
Journal: Int Immunol
Title: Over-expression of CD3 epsilon transgenes blocks T lymphocyte development.
Volume: 7
Issue: 3
Pages: 435-48
Publication
First Author: Wang B
Year: 1999
Journal: J Immunol
Title: T lymphocyte development in the absence of CD3 epsilon or CD3 gamma delta epsilon zeta.
Volume: 162
Issue: 1
Pages: 88-94
Publication
First Author: Roberts NA
Year: 2009
Journal: Eur J Immunol
Title: Absence of thymus crosstalk in the fetus does not preclude hematopoietic induction of a functional thymus in the adult.
Volume: 39
Issue: 9
Pages: 2395-402
Publication
First Author: Holländer GA
Year: 1995
Journal: Immunity
Title: Severe colitis in mice with aberrant thymic selection.
Volume: 3
Issue: 1
Pages: 27-38
Genotype
Symbol: Tg(CD3E)26Cpt/Tg(CD3E)26Cpt
Background: involves: C57BL/6J * CBA/J
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Cd3e/Cd3e Tg(CD3E)26Cpt/?
Background: involves: 129S4/SvJae * C57BL/6 * CBA
Zygosity: cx
Has Mutant Allele: true
Publication
First Author: Holländer GA
Year: 1995
Journal: Nature
Title: Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes.
Volume: 373
Issue: 6512
Pages: 350-3
Publication
First Author: Babu S
Year: 1998
Journal: J Immunol
Title: Host NK cells are required for the growth of the human filarial parasite Brugia malayi in mice.
Volume: 161
Issue: 3
Pages: 1428-32
Strain
Attribute String: mutant stock, targeted mutation, transgenic
Publication
First Author: Klug DB
Year: 2000
Journal: J Immunol
Title: Transgenic expression of cyclin D1 in thymic epithelial precursors promotes epithelial and T cell development.
Volume: 164
Issue: 4
Pages: 1881-8
Publication
First Author: Abadía-Molina AC
Year: 2006
Journal: Gastroenterology
Title: CD48 controls T-cell and antigen-presenting cell functions in experimental colitis.
Volume: 130
Issue: 2
Pages: 424-34
Publication
First Author: Ashkar AA
Year: 1999
Journal: Biol Reprod
Title: Interferon-gamma contributes to the normalcy of murine pregnancy.
Volume: 61
Issue: 2
Pages: 493-502
Publication
First Author: Bekiaris V
Year: 2009
Journal: Eur J Immunol
Title: NK cells protect secondary lymphoid tissue from cytomegalovirus via a CD30-dependent mechanism.
Volume: 39
Issue: 10
Pages: 2800-8
Publication
First Author: Wang N
Year: 1998
Journal: Int Immunol
Title: Expression of a CD3 epsilon transgene in CD3 epsilon(null) mice does not restore CD3 gamma and delta expression but efficiently rescues T cell development from a subpopulation of prothymocytes.
Volume: 10
Issue: 12
Pages: 1777-88
Publication
First Author: Farnoud AM
Year: 2015
Journal: Infect Immun
Title: The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway.
Volume: 83
Issue: 7
Pages: 2705-13
Publication
First Author: Jepsen SL
Year: 2019
Journal: Am J Physiol Endocrinol Metab
Title: Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice.
Volume: 317
Issue: 6
Pages: E1081-E1093
Publication
First Author: Pozdnyakova O
Year: 2003
Journal: J Immunol
Title: Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice.
Volume: 170
Issue: 1
Pages: 84-90
Publication
First Author: Guimond MJ
Year: 1996
Journal: Am J Reprod Immunol
Title: Pregnancy-associated uterine granulated metrial gland cells in mutant and transgenic mice.
Volume: 35
Issue: 6
Pages: 501-9
Publication
First Author: Guimond MJ
Year: 1997
Journal: Biol Reprod
Title: Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice.
Volume: 56
Issue: 1
Pages: 169-79
Publication
First Author: Huber VC
Year: 2001
Journal: J Immunol
Title: Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections.
Volume: 166
Issue: 12
Pages: 7381-8
Publication
First Author: Louten J
Year: 2006
Journal: J Immunol
Title: Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection.
Volume: 177
Issue: 5
Pages: 3266-72
Publication
First Author: Tokoro Y
Year: 1998
Journal: J Immunol
Title: A mouse carrying genetic defect in the choice between T and B lymphocytes.
Volume: 161
Issue: 9
Pages: 4591-8
Publication
First Author: Klug DB
Year: 2002
Journal: J Immunol
Title: Cutting edge: thymocyte-independent and thymocyte-dependent phases of epithelial patterning in the fetal thymus.
Volume: 169
Issue: 6
Pages: 2842-5
Publication
First Author: Wang XP
Year: 2006
Journal: Mol Cell Endocrinol
Title: Alterations in glucose homeostasis in SSTR1 gene-ablated mice.
Volume: 247
Issue: 1-2
Pages: 82-90
Publication  
First Author: Yamamoto M
Year: 2018
Journal: JCI Insight
Title: Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.
Volume: 3
Issue: 19
Publication
First Author: Zuklys S
Year: 2000
Journal: J Immunol
Title: Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Volume: 165
Issue: 4
Pages: 1976-83
Publication
First Author: Strowski MZ
Year: 2000
Journal: Endocrinology
Title: Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
Volume: 141
Issue: 1
Pages: 111-7
Publication
First Author: Withers DR
Year: 2012
Journal: J Immunol
Title: Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue.
Volume: 189
Issue: 5
Pages: 2094-8
Protein
Organism: Mus musculus/domesticus
Length: 127  
Fragment?: false
Publication
First Author: Patel YC
Year: 1997
Journal: Trends Endocrinol Metab
Title: Somatostatin receptors.
Volume: 8
Issue: 10
Pages: 398-405
Publication
First Author: Kumar U
Year: 1999
Journal: Diabetes
Title: Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
Volume: 48
Issue: 1
Pages: 77-85
Publication
First Author: Ludvigsen E
Year: 2004
Journal: J Histochem Cytochem
Title: Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats.
Volume: 52
Issue: 3
Pages: 391-400
Publication
First Author: Schreff M
Year: 2000
Journal: J Neurosci
Title: Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain.
Volume: 20
Issue: 10
Pages: 3785-97
Publication
First Author: Florio T
Year: 2003
Journal: Endocrinology
Title: Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.
Volume: 144
Issue: 4
Pages: 1574-84
Protein Domain
Type: Family
Description: Somatostatin (SST), also known as somatotropin release-inhibiting factor (SRIF), is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Somatostatin has a wide distribution throughout the central nervous system (CNS) as well as in peripheral tissues, for example in the pituitary, pancreas and stomach. The various actions of somatostatin are mediated by a family of rhodopsin-like G protein-coupled receptors, which comprise of five distinct subtypes: Somatostatin receptor 1 (SSTR1), Somatostatin receptor 2 (SSTR2), Somatostatin receptor 3 (SSTR3), Somatostatin receptor 4 (SSTR4) and Somatostatin receptor 5 (SSTR5) [, , ]. These subtypes are widely expressed in many tissues [, , , , , ], and frequently multiple subtypes coexist in the same cell []. The somatostatin receptor subtypes also share common signalling pathways, such as the inhibition of adenylyl cyclase [, ], activation of phosphotyrosine phosphatase (PTP), and modulation of mitogen-activated protein kinase (MAPK) through G protein-dependent mechanisms. Some of the subtypes are also coupled to inward rectifying K+ channels (SSTR2, SSTR3, SSTR4, SSTR5) [, ], to voltage-dependent Ca2+ channels (SSTR1, SSTR2) [], to an Na+/H+ exchanger (SSTR1), AMPA/kainate glutamate channels (SSTR1, SSTR2), phospholipase C (SSTR2, SSTR5), and phospholipase A2 (SSTR4) []. Amongst the wide spectrum of somatostatin effects, several biological responses have been identified that display absolute or relative subtype selectivity. These include GH secretion (SSTR2 and 5), insulin secretion (SSTR5), glucagon secretion (SSTR2), and immune responses (SSTR2) [].This entry represents SSTR2. In humans has been found in high levels the brain, kidney and pituitary, with lower levels in the jejunum, pancreas, colon and liver. All five human somatostatin receptors expressed in COS-7 cells are coupled to activation of phosphoinositide (PI)-specific PLC-beta; and Ca2+ mobilisation via pertussis toxin-sensitive G protein(s) with an order of potency of SSTR5 >SSTR2 >SSTR3 >SSTR4 >SSTR1 [].
Protein Domain
Type: Family
Description: Somatostatin (SST), also known as somatotropin release-inhibiting factor (SRIF), is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Somatostatin has a wide distribution throughout the central nervous system (CNS) as well as in peripheral tissues, for example in the pituitary, pancreas and stomach. The various actions of somatostatin are mediated by a family of rhodopsin-like G protein-coupled receptors, which comprise of five distinct subtypes: Somatostatin receptor 1 (SSTR1), Somatostatin receptor 2 (SSTR2), Somatostatin receptor 3 (SSTR3), Somatostatin receptor 4 (SSTR4) and Somatostatin receptor 5 (SSTR5) [, , ]. These subtypes are widely expressed in many tissues [, , , , , ], and frequently multiple subtypes coexist in the same cell []. The somatostatin receptor subtypes also share common signalling pathways, such as the inhibition of adenylyl cyclase [, ], activation of phosphotyrosine phosphatase (PTP), and modulation of mitogen-activated protein kinase (MAPK) through G protein-dependent mechanisms. Some of the subtypes are also coupled to inward rectifying K+ channels (SSTR2, SSTR3, SSTR4, SSTR5) [, ], to voltage-dependent Ca2+ channels (SSTR1, SSTR2) [], to an Na+/H+ exchanger (SSTR1), AMPA/kainate glutamate channels (SSTR1, SSTR2), phospholipase C (SSTR2, SSTR5), and phospholipase A2 (SSTR4) []. Amongst the wide spectrum of somatostatin effects, several biological responses have been identified that display absolute or relative subtype selectivity. These include GH secretion (SSTR2 and 5), insulin secretion (SSTR5), glucagon secretion (SSTR2), and immune responses (SSTR2) [].This entry represents SSTR1 []. In humans, it is expressed at high levels in the jejunum and stomach, with lower levels in the pancreas, colon and kidney, but it is absent in the brain. Conversely, in rodent tissue, high levels are found in the brain, but are absent in peripheral tissues []. All five human somatostatin receptors expressed in COS-7 cells are coupled to activation of phosphoinositide (PI)-specific PLC-beta; and Ca2+ mobilisation via pertussis toxin-sensitive G protein(s) with an order of potency of SSTR5 >SSTR2 >SSTR3 >SSTR4 >SSTR1 [].
Protein Domain
Type: Family
Description: Somatostatin (SST), also known as somatotropin release-inhibiting factor (SRIF), is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Somatostatin has a wide distribution throughout the central nervous system (CNS) as well as in peripheral tissues, for example in the pituitary, pancreas and stomach. The various actions of somatostatin are mediated by a family of rhodopsin-like G protein-coupled receptors, which comprise of five distinct subtypes: Somatostatin receptor 1 (SSTR1), Somatostatin receptor 2 (SSTR2), Somatostatin receptor 3 (SSTR3), Somatostatin receptor 4 (SSTR4) and Somatostatin receptor 5 (SSTR5) [, , ]. These subtypes are widely expressed in many tissues [, , , , , ], and frequently multiple subtypes coexist in the same cell []. The somatostatin receptor subtypes also share common signalling pathways, such as the inhibition of adenylyl cyclase [, ], activation of phosphotyrosine phosphatase (PTP), and modulation of mitogen-activated protein kinase (MAPK) through G protein-dependent mechanisms. Some of the subtypes are also coupled to inward rectifying K+ channels (SSTR2, SSTR3, SSTR4, SSTR5) [, ], to voltage-dependent Ca2+ channels (SSTR1, SSTR2) [], to an Na+/H+ exchanger (SSTR1), AMPA/kainate glutamate channels (SSTR1, SSTR2), phospholipase C (SSTR2, SSTR5), and phospholipase A2 (SSTR4) []. Amongst the wide spectrum of somatostatin effects, several biological responses have been identified that display absolute or relative subtype selectivity. These include GH secretion (SSTR2 and 5), insulin secretion (SSTR5), glucagon secretion (SSTR2), and immune responses (SSTR2) [].This entry represents SST5R. It is expressed in range of tissues including the small intestine, heart, adrenal, cerebellum, pituitary, placenta and skeletal muscle. It is also expressed in pancreatic islets [], where somatostatin is a known regulator of insulin and glucagon secretion. All five human somatostatin receptors expressed in COS-7 cells have been shown to couple to activation of phosphoinositide (PI)-specific PLC-beta; and Ca2+ mobilisation via pertussis toxin-sensitive G protein(s) with an order of potency of SSTR5 >SSTR2 >SSTR3 >SSTR4 >SSTR1 [].
Protein Domain
Type: Family
Description: Somatostatin (SST), also known as somatotropin release-inhibiting factor (SRIF), is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Somatostatin has a wide distribution throughout the central nervous system (CNS) as well as in peripheral tissues, for example in the pituitary, pancreas and stomach. The various actions of somatostatin are mediated by a family of rhodopsin-like G protein-coupled receptors, which comprise of five distinct subtypes: Somatostatin receptor 1 (SSTR1), Somatostatin receptor 2 (SSTR2), Somatostatin receptor 3 (SSTR3), Somatostatin receptor 4 (SSTR4) and Somatostatin receptor 5 (SSTR5) [, , ]. These subtypes are widely expressed in many tissues [, , , , , ], and frequently multiple subtypes coexist in the same cell []. The somatostatin receptor subtypes also share common signalling pathways, such as the inhibition of adenylyl cyclase [, ], activation of phosphotyrosine phosphatase (PTP), and modulation of mitogen-activated protein kinase (MAPK) through G protein-dependent mechanisms. Some of the subtypes are also coupled to inward rectifying K+ channels (SSTR2, SSTR3, SSTR4, SSTR5) [, ], to voltage-dependent Ca2+ channels (SSTR1, SSTR2) [], to an Na+/H+ exchanger (SSTR1), AMPA/kainate glutamate channels (SSTR1, SSTR2), phospholipase C (SSTR2, SSTR5), and phospholipase A2 (SSTR4) []. Amongst the wide spectrum of somatostatin effects, several biological responses have been identified that display absolute or relative subtype selectivity. These include GH secretion (SSTR2and 5), insulin secretion (SSTR5), glucagon secretion (SSTR2), and immune responses (SSTR2) [].This entry represents SSTR4. It is present in high levels in the pituitary, but is less abundant in the brain and peripheral tissues [, , ]. All five human somatostatin receptors expressed in COS-7 cells are coupled to activation of phosphoinositide (PI)-specific PLC-beta; and Ca2+ mobilisation via pertussis toxin-sensitive G protein(s) with an order of potency of SSTR5 >SSTR2 >SSTR3 >SSTR4 >SSTR1 [].
Protein Domain
Type: Family
Description: Somatostatin (SST), also known as somatotropin release-inhibiting factor (SRIF), is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Somatostatin has a wide distribution throughout the central nervous system (CNS) as well as in peripheral tissues, for example in the pituitary, pancreas and stomach. The various actions of somatostatin are mediated by a family of rhodopsin-like G protein-coupled receptors, which comprise of five distinct subtypes: Somatostatin receptor 1 (SSTR1), Somatostatin receptor 2 (SSTR2), Somatostatin receptor 3 (SSTR3), Somatostatin receptor 4 (SSTR4) and Somatostatin receptor 5 (SSTR5) [, , ]. These subtypes are widely expressed in many tissues [, , , , , ], and frequently multiple subtypes coexist in the same cell []. The somatostatin receptor subtypes also share common signalling pathways, such as the inhibition of adenylyl cyclase [, ], activation of phosphotyrosine phosphatase (PTP), and modulation of mitogen-activated protein kinase (MAPK) through G protein-dependent mechanisms. Some of the subtypes are also coupled to inward rectifying K+ channels (SSTR2, SSTR3, SSTR4, SSTR5) [, ], to voltage-dependent Ca2+ channels (SSTR1, SSTR2) [], to an Na+/H+ exchanger (SSTR1), AMPA/kainate glutamate channels (SSTR1, SSTR2), phospholipase C (SSTR2, SSTR5), and phospholipase A2 (SSTR4) []. Amongst the wide spectrum of somatostatin effects, several biological responses have been identified that display absolute or relative subtype selectivity. These include GH secretion (SSTR2 and 5), insulin secretion (SSTR5), glucagon secretion (SSTR2), and immune responses (SSTR2) [].This entry represents SSTR3. It is widely distributed in mouse brain, with high levels in the forebrain, hippocampus and amygdala; moderate levels are also present in the substantia nigra. All five human somatostatin receptors expressed in COS-7 cells are coupled to activation of phosphoinositide (PI)-specific PLC-beta; and Ca2+ mobilisation via pertussis toxin-sensitive G protein(s) with an order of potency of SSTR5 >SSTR2 >SSTR3 >SSTR4 >SSTR1 []. Inhibition of angiogenesis has been shown to be via the SSTR3, and involves the inhibition of MAPK and endothelial nitric oxide synthase (eNOS) activity [].
Publication
First Author: Yasuda K
Year: 1992
Journal: J Biol Chem
Title: Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.
Volume: 267
Issue: 28
Pages: 20422-8
Publication
First Author: Yamada Y
Year: 1992
Journal: Proc Natl Acad Sci U S A
Title: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.
Volume: 89
Issue: 1
Pages: 251-5
Publication
First Author: Patel YC
Year: 1999
Journal: Front Neuroendocrinol
Title: Somatostatin and its receptor family.
Volume: 20
Issue: 3
Pages: 157-98
Publication
First Author: Bruno JF
Year: 1993
Journal: Endocrinology
Title: Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat.
Volume: 133
Issue: 6
Pages: 2561-7
Publication
First Author: O'Carroll AM
Year: 1994
Journal: Mol Pharmacol
Title: Characterization of cloned human somatostatin receptor SSTR5.
Volume: 46
Issue: 2
Pages: 291-8
Publication
First Author: Buscail L
Year: 1994
Journal: Proc Natl Acad Sci U S A
Title: Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
Volume: 91
Issue: 6
Pages: 2315-9
Publication
First Author: Rohrer L
Year: 1993
Journal: Proc Natl Acad Sci U S A
Title: Cloning and characterization of a fourth human somatostatin receptor.
Volume: 90
Issue: 9
Pages: 4196-200
Publication
First Author: Gugger M
Year: 2004
Journal: Gut
Title: Cellular detection of sst2A receptors in human gastrointestinal tissue.
Volume: 53
Issue: 10
Pages: 1431-6
Publication
First Author: Siehler S
Year: 1999
Journal: Naunyn Schmiedebergs Arch Pharmacol
Title: Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.
Volume: 360
Issue: 5
Pages: 510-21
Publication
First Author: Law SF
Year: 1995
Journal: Cell Signal
Title: Somatostatin receptor activation of cellular effector systems.
Volume: 7
Issue: 1
Pages: 1-8
Publication
First Author: Kreienkamp HJ
Year: 1997
Journal: FEBS Lett
Title: Coupling of rat somatostatin receptor subtypes to a G-protein gated inwardly rectifying potassium channel (GIRK1).
Volume: 419
Issue: 1
Pages: 92-4
Publication
First Author: Akbar M
Year: 1994
Journal: FEBS Lett
Title: Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells.
Volume: 348
Issue: 2
Pages: 192-6
Publication
First Author: Ripen AM
Year: 2011
Journal: Eur J Immunol
Title: Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit β5t.
Volume: 41
Issue: 5
Pages: 1278-87
Publication
First Author: Yu P
Year: 2002
Journal: J Immunol
Title: B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion.
Volume: 168
Issue: 10
Pages: 5117-23
Publication
First Author: Møller LN
Year: 2003
Journal: Biochim Biophys Acta
Title: Somatostatin receptors.
Volume: 1616
Issue: 1
Pages: 1-84
Publication
First Author: Hoyer D
Year: 1995
Journal: Trends Pharmacol Sci
Title: Classification and nomenclature of somatostatin receptors.
Volume: 16
Issue: 3
Pages: 86-8
Publication
First Author: Bénézech C
Year: 2015
Journal: Nat Immunol
Title: Inflammation-induced formation of fat-associated lymphoid clusters.
Volume: 16
Issue: 8
Pages: 819-828
Publication
First Author: Nakagawa Y
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Thymic nurse cells provide microenvironment for secondary T cell receptor α rearrangement in cortical thymocytes.
Volume: 109
Issue: 50
Pages: 20572-7
Protein
Organism: Mus musculus/domesticus
Length: 362  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 385  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 428  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 369  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 391  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 385  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 391  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 121  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 385  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 191  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 206  
Fragment?: false